AcclaimIP-ad

Match Document Document Title
US20110250153 OLIGOMERIC BIOSURFACTANTS IN DERMATOCOSMETIC COMPOSITIONS  
Oligomeric acylated biosurfactants (“OABs”) having low critical micelle concentrations of from about 1.0 ppm to about 200 ppm, preferably less than about 50 ppm, in an aqueous solution of Minimal...
US20140121172 FORMULATIONS CONTAINING LABELS FOR MEDICAL DIAGNOSTICS  
Systems, techniques and methods for estimating the metabolic state or flux, e.g., the body energy state (“BES”) of a patient, are disclosed. The BES provides deep insight into the nutritional...
US20130287756 COMPOSITION AND METHOD TO ALLEVIATE JOINT PAIN  
Beneficial and synergistic effects for alleviating joint pain and symptoms of osteoarthritis and/or rheumatoid arthritis have been found with krill oil and/or marine oil in combination with other...
US20110020316 COMPOSITION AND METHOD TO ALLEVIATE JOINT PAIN  
Beneficial and synergistic effects for alleviating joint pain and symptoms of osteoarthritis and/or rheumatoid arthritis have been found with krill oil and/or marine oil in combination with other...
US20120128762 Sphingomyelin Liposomes for the Treatment of Hyperactive Bladder Disorders  
The present invention provides pharmaceutical compositions and methods for the instillation of lipid vehicles comprised of liposomes containing sphingomyelin or sphingomyelin metabolites to...
US20110212157 DERMAL DELIVERY  
The present invention describes systems and methods for treating disorders and/or conditions associated with the dermal level of the skin. Such disorders include acne, hyperhidrosis, bromhidrosis,...
US20150110718 METHODS AND KITS FOR DETERMINING A PLACEBO PROFILE IN SUBJECTS FOR CLINICAL TRIALS AND FOR TREATMENT OF PATIENTS  
The present invention is directed to methods and assays for identifying subjects participating in clinical trials that may exhibit a placebo response and identifying treatments for subjects with...
US20110028382 TREATMENT OF ORAL PHARYNGEAL DYSPHAGIA  
The invention provides compounds for use in a method of treating oral pharyngeal dysphagia in an individual and related products. One embodiment of the invention comprises administering to an...
US20110152205 APPLICATION OF PUERARIN IN THE PREPARATION OF P2X3 MEDIATED DRUGS FOR PAIN/NERVOUS SYSTEM DISEASES  
The invention relates to the new usage of puerarin in the field of pharmaceutical products, in other words, it relates to the application of puerarin in the preparation of drugs for P2X3 mediated...
US20140323391 BIOMARKERS FOR THE MOLECULAR CLASSIFICATION OF BACTERIAL INFECTION  
Disclosed herein are biomarkers useful for identifying and/or classifying bacterial infections in a subject.
US20140274913 METHODS FOR TREATING INFLAMMATION, AUTOIMMUNE DISORDERS AND PAIN  
Compositions and methods for treating, reducing, or preventing a disease or symptom such as gingivitis, periodontitis, gastritis, colitis, ileitis, Crohn's disease, chronic inflammatory intestinal...
US20130022661 BIO-REMODABLE BONE AUGMENTATION DEVICE AND METHOD  
A bio-remodable augmentation device including an implantable member configured for maintaining space in a bone defect. The implantable member is formed from a bio-remodable composite having...
US20120202753 INHIBITING INFLAMMATION WITH MILK OLIGOSACCHARIDES  
A method of inhibiting inflammation in a subject comprising the administration of milk oligosaccharides or glycoconjugates containing milk oligosaccharides is disclosed.
US20110104228 SELF-ELIMINATING COATINGS  
The invention features the use of a matrix consisting of low molecular weight components for use as a self-eliminating coating for implantable medical devices. The matrix coatings can be used to...
US20120244222 OSMOTIC MEDIATED RELEASE SYNTHETIC NANOCARRIERS  
This invention relates, at least in part, to osmotic mediated release barrier-free synthetic nanocarriers and methods of production and use.
US20150133366 COMPOSITIONS AND METHODS FOR TREATING CLOSTRIDIUM INFECTION AND PREVENTING RECURRENCE OF INFECTION  
C. difficile infection (CDI) is the most common cause of antibiotic-associated diarrhea. Unfortunately, antibiotic therapy remains as the standard treatment for this antibiotic-induced disease and...
US20110311442 DIRECT CELLULAR ENERGY DELIVERY SYSTEM  
A lipid vesicle comprising a phospholipid which is a stable vesicle former and at least one unstable vesicle forming member, wherein the unstable vesicle forming member is selected from the group...
US20130059802 BORON-CONTAINING SMALL MOLECULES  
This invention relates to compounds useful for treating fungal infections, more specifically topical treatment of onychomycosis and/or cutaneous fungal infections. This invention is directed to...
US20120010160 Rapidly Dissolving Oral Strip of Sugar for Hypoglycemia  
A method of orally administering measured doses of sugar into the bloodstream for controlling glucose levels, particularly for those individuals with diabetes or those who experience difficulty...
US20140100174 Treatment for Cancer  
Treatment for Cancer Using A Preparation containing a combination of one or more Natural or Synthetic or a Combination of Natural and Synthetic Boswellic Acids and one or more Natural or Synthetic...
US20110098238 ELUCIDATING LIGAND-BINDING INFORMATION BASED ON PROTEIN TEMPLATES  
A method, computer-readable medium, and system for identifying compounds from chemical libraries that can be used for the therapeutic treatment of a disease or used as lead compounds in a drug...
US20150065438 PREPACKAGED STERILE SYRINGE OR CONTAINERS WITH VARIOUS SUBSTANCE CONCENTRATIONS WITH OR WITHOUT BIOACTIVE REAGENT  
A prepackaged sterile syringe or bottle with various concentrations of tissue and organ biologically stimulating reagents i.e., dextrose, various anthocyanins, anthocyanidins and/or their various...
US20120058099 USE OF HYPOXANTHINE FOR PROMOTION OF NEURONAL OUTGROWTH  
Disclosed herein is a method of promoting neuronal outgrowth in a neuron. The method comprises contacting the neuron with an effective amount of hypoxanthine, to thereby promote neuronal outgrowth...
US20140162964 USE IN BRAIN DEGENERATIVE DISEASES  
Disclosed is a new use for sphingosine-1-phosphate (S1P) receptor agonists in the treatment of progressive dementia or brain degenerative diseases.
US20110053889 Prenatal and postnatal screening and treatment of critical monosaccharide deficiencies for neurologic and immunologic function  
A method for determining the effect of critical glyconutrient dietary supplements in premature and term infants on growth, health, and brain function during early childhood development is...
US20120010162 METHOD FOR TREATMENT OF LUNG INFECTIONS BY ADMINISTRATION OF AMINOGLYCOSIDES BY AEROLISATION  
The present invention regards a novel administration form and a novel administration regime useful in the treatment and prevention of a bacterial lung infection in patient in need thereof, in...
US20120101427 NOVEL PHOTOSENSITIZER FORMULATIONS FOR ORAL ADMINISTRATION  
The present invention provides novel drug formulations for oral administration for diverse medical applications including anticancer, antimetastatic, antibacterial, antifungal, antiprotozoic,...
US20060241058 Acetyl L-carnitine for prevention of painful peripheral neuropathy in patients with type 2 diabetes  
Acetyl L-carnitine, or of one of its pharmaceutically acceptable salts, is useful for the prevention of painful peripheral neuropathy in patients suffering from type 2 diabetes, in which symptoms...
US20110183927 Compositions Comprising Sugar-Cysteine Products  
The present invention provides compositions comprising sugar, cysteine, and/or sugar-cysteine products, methods of preparing the same, and/or using the same.
US20110311478 Combinatorial Methods For Treating Cellular Proliferative Disorders And Immune Deficiencies Using Salicinium  
The present invention provides novel immunotherapeutic compositions and methods useful for treating or preventing microbial infections, weakened immune systems, diseases in which cells have become...
US20120328523 POLYHYDROXYALKANOATES FOR IN VIVO APPLICATIONS  
Polyhydroxyalkanoates (PHAs) from which pyrogen has been removed are provided. PHAs which have been chemically modified to enhance physical and/or chemical properties, for targeting or to modify...
US20120114776 METHODS FOR PREPARING PROBIOTIC NANOPARTICLES  
Various embodiments of the present invention are directed toward a method for preparing probiotic nanoparticles from natural sources, comprising performing a biological preparation phase such as...
US20110059906 Energy status of an individual by enhanced production of an endogenous fuel source  
The present invention relates to a method of improving the energy status of an individual by enhancing the usage of lactate. Improved lactate usage is accomplished through a composition comprising...
US20130064884 COMPOSITION AND METHOD FOR TREATING KETOSIS IN COWS  
A method for prophylactic treatment of ketosis in a calving cow, the method including orally administering to the cow within a time period of about 12 hours after calving an effective dose of from...
US20150011485 COMBINATION THERAPY FOR THE TREATMENT OF DIABETES  
The present invention is directed to co-therapy and methods for the treatment and prevention of glucose-related disorders such as Type 2 diabetes mellitus and Syndrome X. The present invention is...
US20110009347 COMBINATION THERAPY FOR THE TREATMENT OF DIABETES  
The present invention is directed to co-therapy and methods for the treatment and prevention of glucose-related disorders such as Type 2 diabetes mellitus and Syndrome X. The present invention is...
US20110293681 HAND SANITIZING PATCH HAVING AN INTEGRALLY BONDED ANTIMICROBIAL  
The present invention provides for topical adhesive patch that includes a backing having a front side and a back side; a formulation in contact with the front side of the backing, the formulation...
US20130183281 METHODS AND COMPOSITONS FOR CELL-PROLIFERATION-RELATED DISORDERS  
Methods of treating and evaluating subjects having neoactive mutants of IDH (e.g., IDH1 or IDH2).
US20090291877 TREATMENTS USING CITRULLINE  
The invention provides a method and formulation for the treatment or maintenance of conditions that would be benefited from increasing or maintaining Arginine levels in the blood, and having...
US20120058186 THERAPEUTIC OR PROPHYLACTIC AGENT FOR DYSKINESIA  
The present invention relates to a stable orally disintegrating coated tablet containing a drug, wherein the tablet is coated with a coating layer containing a water-soluble substance and a...
US20140243261 Method for treating diabetes and fatty liver disese by stimulating cellular metabolism  
The present invention is a method of treating various diseases and conditions through administering a substantial caloric load coupled with administration of hormone to stimulate the body to...
US20110002881 TREATMENT AND PROPHYLAXIS  
This invention discloses the use of an E-selectin antagonist in methods and compositions for treating or preventing immunocompromised conditions resulting from medical treatment. The present...
US20130084311 Lingual Vestibular Dosage-form and Delivery System for Transmucosal Administration of Pharmaceutical Agents  
A pharmaceutical delivery system enabling the oral transmucosal administration of active pharmaceutical agents in a situation where rapid transmucosal administration is preferred to prevent the...
US20110301103 Methods of Treatment  
The present disclosure provides a biochemical basis of nephrotic syndrome and provides and explanation for the observed proteinuria and other effects. As a result, the present disclosure provides...
US20120087980 STIMULATION OF NEUROREGENERATION BY FLAVONOID GLYCOSIDES  
Flavonoid glycosides, such as isoquercitrin, are shown to stimulate the formation of neuritis and neuronal synapses in neurons and neuronal progenitor (stem) cells.
US20130337055 COMPOSITIONS, METHODS OF TREATMENT AND DIAGNOSTICS FOR TREATMENT OF HEPATIC STEATOSIS ALONE OR IN COMBINATION WITH A HEPATITIS C VIRUS INFECTION  
The present invention is directed to pharmaceutical compositions and methods of treatment that relate to the inhibition, resolution and/or prevention of an array of the manifestations of metabolic...
US20140005099 MARKERS FOR DIAGNOSIS OF PULMONARY INFLAMMATION AND METHODS RELATED THERETO  
The present invention is related to the novel discovery of a number of genes that were identified as systemic markers of pulmonary inflammation. This discovery allows for development of a novel...
US20140303067 TREATMENT OF EOSINOPHILIC ESOPHAGITIS  
The present invention provides a method for the treatment of eosinophilicesophagitis comprising administering non-digestible oligosaccharides.
US20110046083 ACTIVATORS OF PYRUVATE KINASE M2 AND METHODS OF TREATING DISEASE  
The invention described herein features methods, compositions, and kits for the use of activators of PKM2 for the treatment, prevention, or amelioration of diseases related to PKM2 function,...
US20070117762 Use of an alkanoyl L-carnitine for the treatment of the erectile dysfunction  
Erectile dysfunction is treated with a combination of propionyl L-carnitine in combination with sildenafil, apomorphine prostaglandin E1, pentolamine and papaverine.